Skip to content
DefDex

Federal award

QIAGEN, LLC

W81K0223P0109

Contract

Obligated and Ceiling

Obligated (net)
$146,513.33
Ceiling (potential value, not spending)
$185,779.00
Current value
$146,513.33
Gross positive obligations
$262,852.84

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
QIAGEN, LLC · W2GLKC92ZH73
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
QIAGEN, LLC · W2GLKC92ZH73
Awarding agency
Department of War · sub-agency 97DH · office HT9410
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
W81K0223P0109
Award type code
B
Actions
12 · Aug 30, 2023 to Apr 8, 2026
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History12

Award actions
DateFYModAction typeObligationCompany in company totals
Apr 8, 2026FY2026P00011M$0.00
—
Mar 25, 2026FY2026P00010M$0.00
—
Dec 23, 2025FY2026P00009C$37,376.83
—
Sep 17, 2025FY2025P00008B−$51,790.20
—
Mar 5, 2025FY2025P00007G$0.00
—
Nov 6, 2024FY2025P00006B$87,382.06
—
Sep 13, 2024FY2024P00005B−$4,672.50
—
May 9, 2024FY2024P00004B−$59,876.81
—
Mar 22, 2024FY2024P00003G$0.00
—
Oct 11, 2023FY2024P00002C$90,367.10
—
Sep 8, 2023FY2023P00001G$0.00
—
Aug 30, 2023FY20230—$47,726.85
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.